UnitedHealth Other Assets vs Good Will Analysis
UNH Stock | USD 495.35 1.49 0.30% |
UnitedHealth Group financial indicator trend analysis is much more than just breaking down UnitedHealth Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether UnitedHealth Group is a good investment. Please check the relationship between UnitedHealth Group Other Assets and its Good Will accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Other Assets vs Good Will
Other Assets vs Good Will Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of UnitedHealth Group Other Assets account and Good Will. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between UnitedHealth Group's Other Assets and Good Will is 0.4. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Good Will in the same time period over historical financial statements of UnitedHealth Group Incorporated, assuming nothing else is changed. The correlation between historical values of UnitedHealth Group's Other Assets and Good Will is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of UnitedHealth Group Incorporated are associated (or correlated) with its Good Will. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Good Will has no effect on the direction of Other Assets i.e., UnitedHealth Group's Other Assets and Good Will go up and down completely randomly.
Correlation Coefficient | 0.4 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Other Assets
Good Will
An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.Most indicators from UnitedHealth Group's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into UnitedHealth Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. As of now, UnitedHealth Group's Selling General Administrative is increasing as compared to previous years. The UnitedHealth Group's current Sales General And Administrative To Revenue is estimated to increase to 0.19, while Tax Provision is projected to decrease to under 5 B.
2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 285.3B | 322.1B | 371.6B | 390.2B | Depreciation And Amortization | 779M | 1.4B | 4.0B | 4.2B |
UnitedHealth Group fundamental ratios Correlations
Click cells to compare fundamentals
UnitedHealth Group Account Relationship Matchups
UnitedHealth Group fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 173.9B | 197.3B | 212.2B | 245.7B | 278.4B | 292.3B | |
Total Current Liabilities | 61.8B | 72.4B | 78.3B | 89.2B | 99.1B | 104.0B | |
Total Stockholder Equity | 60.4B | 68.3B | 75.0B | 81.5B | 88.8B | 93.2B | |
Property Plant And Equipment Net | 8.7B | 8.6B | 9.0B | 10.1B | 11.5B | 12.0B | |
Net Debt | 29.7B | 26.5B | 24.6B | 34.3B | 42.0B | 44.1B | |
Retained Earnings | 61.2B | 69.3B | 77.1B | 86.2B | 95.8B | 100.6B | |
Cash | 11.0B | 16.9B | 21.4B | 23.4B | 25.4B | 26.7B | |
Non Current Assets Total | 131.3B | 143.6B | 150.4B | 176.6B | 200.0B | 210.0B | |
Non Currrent Assets Other | 94.0B | 102.3B | 107.3B | 12.3B | 17.3B | 10.9B | |
Cash And Short Term Investments | 14.2B | 19.8B | 23.9B | 27.9B | 29.6B | 31.1B | |
Net Receivables | 11.8B | 12.9B | 14.2B | 17.7B | 39.0B | 40.9B | |
Common Stock Shares Outstanding | 966M | 961M | 956M | 950M | 938M | 1.2B | |
Liabilities And Stockholders Equity | 173.9B | 197.3B | 212.2B | 245.7B | 278.4B | 292.3B | |
Non Current Liabilities Total | 49.9B | 54.3B | 57.4B | 70.1B | 80.4B | 84.5B | |
Other Current Assets | 16.6B | 21.1B | 23.6B | 23.5B | 78.4B | 82.4B | |
Other Stockholder Equity | 2.8B | 2.8B | 3.3B | 3.7B | 4.2B | 4.4B | |
Total Liab | 111.7B | 126.8B | 135.7B | 159.4B | 179.5B | 188.5B | |
Total Current Assets | 42.6B | 53.7B | 61.8B | 69.1B | 78.4B | 82.4B | |
Short Long Term Debt Total | 40.7B | 43.5B | 46.0B | 57.6B | 67.4B | 70.8B | |
Intangible Assets | 10.3B | 10.9B | 10.0B | 14.4B | 15.2B | 16.0B | |
Other Current Liab | 33.6B | 42.9B | 47.6B | 54.0B | 58.4B | 61.4B | |
Short Term Debt | 3.9B | 4.8B | 3.6B | 3.1B | 5.3B | 5.6B | |
Accounts Payable | 21.7B | 21.9B | 24.5B | 29.1B | 32.0B | 33.6B | |
Short Term Investments | 3.3B | 2.9B | 2.5B | 4.5B | 4.2B | 4.4B | |
Accumulated Other Comprehensive Income | (3.6B) | (3.8B) | (5.4B) | (8.4B) | (7.0B) | (6.7B) | |
Good Will | 65.7B | 71.3B | 75.8B | 93.4B | 103.7B | 108.9B | |
Property Plant And Equipment Gross | 8.7B | 8.6B | 15.0B | 17.1B | 18.5B | 19.4B | |
Other Liab | 10.0B | 15.7B | 15.1B | 11.8B | 13.5B | 14.2B | |
Other Assets | 13.8B | 52.8B | 107.3B | 20.7B | 23.8B | 13.1B | |
Long Term Debt | 36.8B | 38.6B | 42.4B | 54.5B | 58.3B | 61.2B | |
Property Plant Equipment | 8.7B | 8.6B | 9.0B | 10.1B | 11.6B | 12.2B | |
Current Deferred Revenue | 2.6B | 2.8B | 2.6B | 3.1B | 3.4B | 2.5B | |
Net Tangible Assets | (16.7B) | (14.5B) | 75.0B | (25.1B) | (28.8B) | (27.4B) | |
Noncontrolling Interest In Consolidated Entity | 2.8B | 2.8B | 3.3B | 3.7B | 4.2B | 4.4B | |
Retained Earnings Total Equity | 61.2B | 69.3B | 77.1B | 86.2B | 99.1B | 51.1B | |
Long Term Debt Total | 36.8B | 38.6B | 42.4B | 54.5B | 62.7B | 65.8B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for UnitedHealth Stock analysis
When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is UnitedHealth Group's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.16 | Dividend Share 7.52 | Earnings Share 16.4 | Revenue Per Share 411.257 | Quarterly Revenue Growth 0.086 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.